Mahwish Hussain, MD
Family Medicine · Falls Church, VANPI 1871157495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 30.9% of the total.
Across 81 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$543
- Pfizer$318
- Bausch Health US, LLC$165
- Viiv Healthcare Company$142
- Takeda Pharmaceuticals U.S.A., Inc.$97
- Novo Nordisk$96
- plus $395 from 11 others
What the payments were for
- Food & beverage$1,754100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $543 |
| Pfizer | 16 | $318 |
| Bausch Health US, LLC | 8 | $165 |
| Viiv Healthcare Company | 6 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| Novo Nordisk | 4 | $96 |
| Lundbeck LLC | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Lilly USA, LLC | 2 | $53 |
| Baxter Healthcare | 2 | $41 |
| Tris Pharma Inc | 2 | $38 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Amgen | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Smith+Nephew | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
How this compares
$1,754 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Falls Church
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.